Crescent BDC (CCAP) PT Lowered to $12.50 at B.Riley
Tweet
Share
E-mailGet Alerts CCAP Hot Sheet
Price: $11.08 --0%
Rating Summary:
5 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 9
Rating Summary:
5 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 9
Join SI Premium – FREE
B.Riley analyst Sean-Paul Adams lowered the price target on Crescent BDC (NASDAQ: CCAP) to $12.50 (from $13.50) while maintaining a Neutral rating.
You May Also Be Interested In
- Crescent BDC (CCAP) PT Lowered to $14 at Ladenburg Thalmann
- PTC Therapeutics (PTCT) PT Raised to $109 at Wells Fargo
- BitGo Holdings (BTGO) PT Lowered to $11 at Wells Fargo
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
